Literature DB >> 21107134

Development of postinfection epilepsy after Theiler's virus infection of C57BL/6 mice.

Kerry-Ann A Stewart1, Karen S Wilcox, Robert S Fujinami, H Steve White.   

Abstract

Viral infection of the central nervous system can lead to long-term neurologic defects, including increased risk for the development of epilepsy. We describe the development of the first mouse model of viral-induced epilepsy after intracerebral infection with Theiler's murine encephalomyelitis virus. Mice were monitored with long-term video-electroencephalogram at multiple time points after infection. Most mice exhibited short-term symptomatic seizures within 3 to 7 days of infection. This was followed by a distinct latent period in which no seizures were observed. Prolonged video-electroencephalogram recordings at 2, 4, and 7 months after the initial infection revealed that a significant proportion of the mice developed profound, spontaneous epileptic seizures. Neuropathologic examination revealed hippocampal sclerosis in animals with epilepsy. Theiler's murine encephalomyelitis virus-infected C57BL/6 mice represent a novel "hit-and-run" model to investigate mechanisms underlying viral-induced short-term symptomatic seizures, epileptogenesis, and epilepsy. Importantly, this model will also be useful to investigate novel therapies for the treatment and prevention of epilepsy.

Entities:  

Mesh:

Year:  2010        PMID: 21107134      PMCID: PMC3077028          DOI: 10.1097/NEN.0b013e3181ffc420

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  34 in total

1.  Assessment of inhibition and epileptiform activity in the septal dentate gyrus of freely behaving rats during the first week after kainate treatment.

Authors:  J L Hellier; P R Patrylo; P Dou; M Nett; G M Rose; F E Dudek
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

2.  Functional and molecular properties of human astrocytes in acute hippocampal slices obtained from patients with temporal lobe epilepsy.

Authors:  W Schröder; S Hinterkeuser; G Seifert; J Schramm; R Jabs; G P Wilkin; C Steinhäuser
Journal:  Epilepsia       Date:  2000       Impact factor: 5.864

Review 3.  Picornaviruses and cell death.

Authors:  Eric J Buenz; Charles L Howe
Journal:  Trends Microbiol       Date:  2005-12-06       Impact factor: 17.079

Review 4.  Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy.

Authors:  Robert J Delorenzo; David A Sun; Laxmikant S Deshpande
Journal:  Pharmacol Ther       Date:  2004-12-09       Impact factor: 12.310

5.  Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy.

Authors:  C G Bien; H Urbach; J Schramm; B M Soeder; A J Becker; R Voltz; A Vincent; C E Elger
Journal:  Neurology       Date:  2007-09-18       Impact factor: 9.910

6.  Theiler's virus infection chronically alters seizure susceptibility.

Authors:  Kerry-Ann A Stewart; Karen S Wilcox; Robert S Fujinami; H Steve White
Journal:  Epilepsia       Date:  2009-12-01       Impact factor: 5.864

7.  Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6.

Authors:  I L Campbell; C R Abraham; E Masliah; P Kemper; J D Inglis; M B Oldstone; L Mucke
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

8.  ILAE Commission Report. Mesial temporal lobe epilepsy with hippocampal sclerosis.

Authors:  Heinz-Gregor Wieser
Journal:  Epilepsia       Date:  2004-06       Impact factor: 5.864

9.  Role of IFN-gamma in an experimental murine model of West Nile virus-induced seizures.

Authors:  Daniel R Getts; Izuru Matsumoto; Marcus Müller; Meghann Teague Getts; Jane Radford; Bimmi Shrestha; Iain L Campbell; Nicholas J C King
Journal:  J Neurochem       Date:  2007-09-05       Impact factor: 5.372

Review 10.  The neurobiology of epilepsy.

Authors:  Helen E Scharfman
Journal:  Curr Neurol Neurosci Rep       Date:  2007-07       Impact factor: 5.081

View more
  58 in total

1.  Neurotropic viral infections leading to epilepsy: focus on Theiler's murine encephalomyelitis virus.

Authors:  Jane E Libbey; Robert S Fujinami
Journal:  Future Virol       Date:  2011-11       Impact factor: 1.831

2.  Once initiated, viral encephalitis-induced seizures are consistent no matter the treatment or lack of interleukin-6.

Authors:  Jane E Libbey; Nikki J Kennett; Karen S Wilcox; H Steve White; Robert S Fujinami
Journal:  J Neurovirol       Date:  2011-08-11       Impact factor: 2.643

Review 3.  Infections, inflammation and epilepsy.

Authors:  Annamaria Vezzani; Robert S Fujinami; H Steve White; Pierre-Marie Preux; Ingmar Blümcke; Josemir W Sander; Wolfgang Löscher
Journal:  Acta Neuropathol       Date:  2015-09-30       Impact factor: 17.088

4.  Decrease in CA3 inhibitory network activity during Theiler's virus encephalitis.

Authors:  R M Smeal; R Fujinami; H S White; K S Wilcox
Journal:  Neurosci Lett       Date:  2015-10-23       Impact factor: 3.046

Review 5.  Disease modification in epilepsy: from animal models to clinical applications.

Authors:  Melissa L Barker-Haliski; Dan Friedman; Jacqueline A French; H Steve White
Journal:  Drugs       Date:  2015-05       Impact factor: 9.546

6.  Indoleamine 2,3-dioxygenase 1 deletion promotes Theiler's virus-induced seizures in C57BL/6J mice.

Authors:  Michal B Juda; Alexandra K Brooks; Albert E Towers; Gregory G Freund; Robert H McCusker; Andrew J Steelman
Journal:  Epilepsia       Date:  2019-02-15       Impact factor: 5.864

7.  Three immune-mediated disease models induced by Theiler's virus: Multiple sclerosis, seizures and myocarditis.

Authors:  Ikuo Tsunoda; Fumitaka Sato; Seiichi Omura; Mitsugu Fujita; Namie Sakiyama; Ah-Mee Park
Journal:  Clin Exp Neuroimmunol       Date:  2016-10-25

Review 8.  Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening.

Authors:  Melissa Barker-Haliski; H Steve White
Journal:  Neuropharmacology       Date:  2019-08-27       Impact factor: 5.250

9.  Acute treatment with minocycline, but not valproic acid, improves long-term behavioral outcomes in the Theiler's virus model of temporal lobe epilepsy.

Authors:  Melissa L Barker-Haliski; Taylor D Heck; E Jill Dahle; Fabiola Vanegas; Timothy H Pruess; Karen S Wilcox; H Steve White
Journal:  Epilepsia       Date:  2016-10-14       Impact factor: 5.864

10.  The effects of diet on the severity of central nervous system disease: One part of lab-to-lab variability.

Authors:  Jane E Libbey; Daniel J Doty; Jordan T Sim; Matthew F Cusick; June L Round; Robert S Fujinami
Journal:  Nutrition       Date:  2016-01-21       Impact factor: 4.008

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.